Temple University Health System’s preparations for and treatment of patients amidst the coronavirus pandemic continue to be part of the media’s COVID-19 coverage.
- The American Association for Respiratory Care (AARC) highlighted the extraordinary efforts of Temple’s respiratory therapists throughout the COVID-19 pandemic. Gerard J. Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Director of the Temple Lung Center, and Hernan Alvarado Jr., MBA, RRT, RPFT, Associate Vice President of Respiratory Care and Sleep Diagnostics Services, were interviewed for the article. The piece chronicled Temple’s preparations at the onset of the pandemic, described the innovative care therapists provided to patients, and detailed how staff maintained pulmonary diagnostics and sleep services on top of their new responsibilities.
- Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, Clinical Professor and Director of the Postgraduate Year Two Infectious Diseases Residency at the Temple University School of Pharmacy and Clinical Pharmacist Specialist in Infectious Diseases at Temple University Hospital, discussed the preparation and coordination that will be necessary to administer COVID-19 booster shots, particularly at retail pharmacies, with the Wall Street Journal.
- Dr. Gallagher also spoke with VeryWell Health about the logistics of monoclonal antibody treatment for COVID-19 and offered insight to NorthJersey.com about mixing-and-matching COVID-19 vaccines following the approval of booster shots for certain demographics who received the Pfizer vaccine.